National News
Safety Net Provider Drug Pricing Protection Act Introduced to Lower Upfront Clinic Costs
Content Files PDF XML TEXT Metadata download Descriptive Metadata (MODS) Preservation Metadata (PREMIS) All Content and Metadata files, including granules ZIP
Last updated:
Key points
- Representative Jack Bergman introduced HR 10919 to enforce point-of-sale discount pricing for safety net health providers.
- The legislation prohibits pharmaceutical manufacturers from requiring post-purchase rebates or reimbursement mechanisms.
- A bipartisan group of 14 House members backed the bill before its referral to the House Committee on Energy and Commerce.
NewsWK — Community health clinics across the nation could soon see relief from heavy upfront medication costs under new federal legislation. Representative Jack Bergman introduced the bill alongside 13 cosponsors on October 29, 2026. Also, the legislation directly targets financial burdens on local safety net providers.
What does HR 10919 change for local safety net clinics?
The Safety Net Provider Drug Pricing Protection Act mandates upfront price caps for eligible safety net providers.
Specifically, the 340B drug pricing bill bans arrangements where pharmaceutical companies charge high initial prices and refund discounts later. Therefore, federally qualified health centers, sole community hospitals, and state clinics receive direct savings immediately. Ten Democrats and four Republicans currently sponsor the measure.
Why is the prescription drug discount program reform moving forward?
Lawmakers introduced the proposal to safeguard safety net providers from administrative delays and inflated upfront bills. Next, the House Committee on Energy and Commerce received the bill for review.
How does Jack Bergman drug pricing legislation enforce the 340B ceiling price requirement?
The proposal amends Title III of the Public Health Service Act to strictly enforce point-of-sale pricing caps. Drug makers must apply federal discount rules immediately during transactions. Therefore, safety net entities will no longer wait for delayed corporate reimbursements.
- Enforces direct point-of-sale ceiling prices.
- Outlaws delayed manufacturer rebate mechanisms.
- Secures immediate savings for local clinics.
This article was produced with the assistance of AI and reviewed by our editorial team.
Sources
Related: New Legislation Aims to Enhance Efficiency in 340B Drug Pricing Program
See a typo? Report it here.
